Author details

Full Name

Steven E Robinson

Affiliation

University of Colorado Anschutz Medical Campus

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
31781510	IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.	Front Oncol	2019
31781510	IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.	Front Oncol	2019
29054607	Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the Î²-Catenin Pathway in the Hair Follicle Bulge Stem Cells.	J Invest Dermatol	2018
28940260	Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.	Int J Cancer	2018
29054607	Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the Î²-Catenin Pathway in the Hair Follicle Bulge Stem Cells.	J Invest Dermatol	2018
28940260	Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.	Int J Cancer	2018
27086916	Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.	Oncotarget	2017
27086916	Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.	Oncotarget	2017
28296713	Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.	Melanoma Res	2017
27864876	Kinase gene fusions in defined subsets of melanoma.	Pigment Cell Melanoma Res	2017
28296713	Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.	Melanoma Res	2017
27864876	Kinase gene fusions in defined subsets of melanoma.	Pigment Cell Melanoma Res	2017
27026619	IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.	J Am Med Inform Assoc	2016
27026619	IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.	J Am Med Inform Assoc	2016
27193292	Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.	Exp Dermatol	2016
27829238	Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.	Oncotarget	2016
27829238	Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.	Oncotarget	2016
27193292	Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.	Exp Dermatol	2016
25350317	Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells.	J Invest Dermatol	2015
25822579	Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.	J Invest Dermatol	2015
25728676	Transcriptional repression of IFNÎ²1 by ATF2 confers melanoma resistance to therapy.	Oncogene	2015
25350317	Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells.	J Invest Dermatol	2015
26203640	SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype.	J Invest Dermatol	2015
26203640	SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype.	J Invest Dermatol	2015
25728676	Transcriptional repression of IFNÎ²1 by ATF2 confers melanoma resistance to therapy.	Oncogene	2015
25822579	Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.	J Invest Dermatol	2015
24008424	Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.	J Invest Dermatol	2014
25380187	Long term storage of dry versus frozen RNA for next generation molecular studies.	PLoS One	2014
24008424	Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.	J Invest Dermatol	2014
24476799	Therapeutic monoclonal antibodies in human breast milk: a case study.	Melanoma Res	2014
24913145	A highly recurrent RPS27 5'UTR mutation in melanoma.	Oncotarget	2014
25380187	Long term storage of dry versus frozen RNA for next generation molecular studies.	PLoS One	2014
24913145	A highly recurrent RPS27 5'UTR mutation in melanoma.	Oncotarget	2014
24476799	Therapeutic monoclonal antibodies in human breast milk: a case study.	Melanoma Res	2014
23303449	CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.	J Invest Dermatol	2013
23901115	Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.	Proc Natl Acad Sci U S A	2013
23936495	Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-Î²1 and EMMPRIN.	PLoS One	2013
23303449	CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.	J Invest Dermatol	2013
23901115	Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.	Proc Natl Acad Sci U S A	2013
23936495	Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-Î²1 and EMMPRIN.	PLoS One	2013
22189301	The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.	Melanoma Res	2012
22887839	ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.	Stem Cells	2012
22622430	Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.	J Invest Dermatol	2012
22189301	The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.	Melanoma Res	2012
22887839	ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.	Stem Cells	2012
22622430	Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.	J Invest Dermatol	2012
21499247	Exome sequencing identifies GRIN2A as frequently mutated in melanoma.	Nat Genet	2011
24850203	Recovery of MicroRNA from Stored Human Peripheral Blood Samples.	Biopreserv Biobank	2011
21499247	Exome sequencing identifies GRIN2A as frequently mutated in melanoma.	Nat Genet	2011
21698244	Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.	PLoS One	2011

1 - 50 of 56

Kerrie L Marie

The University of Manchester

Career Start Year 2015

Number of shared co-authors 4

Manoela Tiago

Thomas Jefferson University

Career Start Year 2011

Number of shared co-authors 3

Mitchell P Levesque

University Hospital Zurich

Career Start Year 2009

Number of shared co-authors 15

Xinmin Li

University of California los angeles

Career Start Year 2008

Number of shared co-authors 0

Lawrence N Kwong

The University of Texas MD Anderson Cancer Center

Career Start Year 2007

Number of shared co-authors 8

Riyue Bao

UPMC Hillman Cancer Center

Career Start Year 2007

Number of shared co-authors 2

Nicola Waddell

QIMR Berghofer Medical Research Institute

Career Start Year 2006

Number of shared co-authors 10

M Raza Zaidi

Northwell Health Cancer Institute

Career Start Year 2006

Number of shared co-authors 3

Harriet M Kluger

Yale School of Medicine

Career Start Year 2003

Number of shared co-authors 12

Chi-Ping Day

Center for Cancer Research, National Cancer Institute

Career Start Year 2002

Number of shared co-authors 6

Marcory C R F van Dijk

1Rijnstate Hospital

Career Start Year 2001

Number of shared co-authors 0

Daniela Mihic-Probst

University Hospital Zurich

Career Start Year 2001

Number of shared co-authors 4

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 0

Patricia Porter-Gill

Arkansas Children's Research Institute

Career Start Year 1998

Number of shared co-authors 7

Diana N Nunes

A.C. Camargo Cancer Center

Career Start Year 1998

Number of shared co-authors 1

Travis J Hollmann

Memorial Sloan Kettering Cancer Center

Career Start Year 1998

Number of shared co-authors 3

Raymond J Cho

University of California san francisco

Career Start Year 1998

Number of shared co-authors 3

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 1

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 2

Hae-Ock Lee

College of Medicine, The Catholic University of Korea

Career Start Year 1996

Number of shared co-authors 0

Woong-Yang Park

Samsung Genome Institute, Samsung Medical Center

Career Start Year 1995

Number of shared co-authors 0

Anamaria A Camargo

Hospital Sirio-Libanes

Career Start Year 1994

Number of shared co-authors 0

Ashani T Weeraratna

Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine

Career Start Year 1992

Number of shared co-authors 13

Levi A Garraway

Broad Institute of Harvard and MIT

Career Start Year 1991

Number of shared co-authors 7

Fredrik Pont??n

Uppsala University

Career Start Year 1991

Number of shared co-authors 0

Suzanne Carreira

The Institute of Cancer Research

Career Start Year 1990

Number of shared co-authors 0

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 0

Grant A McArthur

University of Melbourne

Career Start Year 1986

Number of shared co-authors 10

David E Fisher

Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School

Career Start Year 1983

Number of shared co-authors 12

Meenhard Herlyn

Ellen and Ronald Caplan Cancer Center, The Wistar Institute

Career Start Year 1972

Number of shared co-authors 15

row(s) 1 - 30 of 30

William A Robinson

National Centre for Asbestos Related Diseases, University of Western Australia

Co-authored papers 28

Rene Gonzalez

University of Colorado Anschutz Medical Campus

Co-authored papers 6

Martin D McCarter

University of Colorado School of Medicine

Co-authored papers 5

Steven A Rosenberg

University of Colorado School of Medicine

Co-authored papers 4

Jeffrey E Gershenwald

The University of Texas MD Anderson Cancer Center

Co-authored papers 4

Michael A Davies

The University of Texas MD Anderson Cancer Center

Co-authored papers 4

Aik Choon Tan

Huntsman Cancer Institute, The University of Utah

Co-authored papers 4

Jared J Gartner

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Yardena Samuels

Weizmann Institute of Science

Co-authored papers 4

Xiaomu Wei

Cornell University

Co-authored papers 3

Nicholas K Hayward

QIMR Berghofer Medical Research Institute

Co-authored papers 3

Jimmy C Lin

National Human Genome Research Institute, US National Institutes of Health

Co-authored papers 3

Ken Dutton-Regester

QIMR Berghofer Medical Research Institute

Co-authored papers 3

Todd D Prickett

National Cancer Institute

Co-authored papers 3

Jamie K Teer

H. Lee Moffitt Cancer Center and Research Institute

Co-authored papers 3

Stephen C J Parker

University of Michigan ann arbor

Co-authored papers 2

Guo Chen

China Pharmaceutical University

Co-authored papers 2

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 2

Susan R Davis

Co-authored papers 2

Elliott H Margulies

National Human Genome Research Institute, National Institutes of Health

Co-authored papers 2

Hannah Carter

University of California San Diego

Co-authored papers 1

Yongmei Feng

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1